High Intensity Versus Low Level Laser Therapy in Treatment of Patients With Subacromial Impingement Syndrome: A Randomized, Double-blind, Controlled Trial.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Subacromial Impingement Syndrome
- Sponsor
- Cairo University
- Enrollment
- 42
- Locations
- 1
- Primary Endpoint
- pain intensity
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
Shoulder pain is the third most common musculoskeletal problem after lumbar and neck diseases in clinical practice, and the most common cause of shoulder pain is subacromial impingement syndrome. The main goal of treatment is to reduce pain and to solve the mechanical problem that causes functional impairment. Low-level laser treatment is an increasingly used treatment modality in the treatment of subacromial impingement syndrome as in many musculoskeletal diseases, as it promotes cell proliferation and tissue regeneration by its anti-inflammatory and photobiostimulation properties. Also, High-intensity laser therapy is a treatment method that is gaining popularity in the recent years. These ultra-short impulses effect a deep action in the biological tissue (3-4 cm), with a homogeneous distribution of the light source in the irradiated soft tissue, but without excessive thermal enhancements. It reduces pain and edema with photomechanic effects in deep tissues. As far as the investigators know, there are no studies comparing these two treatment modalities in subacromial impingement syndrome yet. This study was planned to compare the efficacy of High-intensity laser therapy and low-intensity laser therapy in treatment of patients with subacromial impingement syndrome.
Investigators
Marwa Shafiek Mustafa Saleh
assistance professor doctor
Cairo University
Eligibility Criteria
Inclusion Criteria
- •shoulder pain for at least one month
- •male and female patients with age range from 25-45 years old
- •positive impingement test results
- •stage I or II disease according to the Neer classification, confirmed by MRI
- •visual analog scale score greater than 40 mm.
Exclusion Criteria
- •patients will be excluded if they have:
- •major trauma to the shoulder
- •stage III subacromial impingement syndrome
- •diabetes mellitus
- •hypothyroidism
- •calcific tendinitis
- •adhesive capsulitis (forward flexion less than 160, horizontal abduction less than 160
- •installation of cardiac pacemaker
- •history of a physical therapy program for the same shoulder in the last 6 months.
Outcomes
Primary Outcomes
pain intensity
Time Frame: change from base line at three weeks
Pain will be evaluated by a visual analogue scale (VAS). The patient will be asked to mark the severity of pain on a 100-mm line with "no pain" on one end and "most unbearable pain" on the other end
Secondary Outcomes
- Pittsburgh Sleep Quality Index (PSQI)(change from baseline at three weeks)
- pain pressure threshold(change from baseline at three weeks)
- shoulder range of motion(change from baseline at three weeks)
- Shoulder Pain and Disability Index(change from baseline at three weeks)